Clinical Trial Update: Safety Study of a Human Metapneumovirus Challenge Virus in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of a human metapneumovirus challenge virus in healthy adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Metapneumovirus Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Human Metapneumovirus | Phase 1 | Status: COMPLETED